Add like
Add dislike
Add to saved papers

Examination of the increased risk for falls among individuals with knee osteoarthritis: A CLSA population based study.

OBJECTIVE: To characterize the profile of individuals with and without knee osteoarthritis (OA) who fell, and to identify factors contributing to an individual with knee OA experiencing one or multiple injurious falls.

METHODS: Data are from the baseline and 3-year follow-up questionnaires of the Canadian Longitudinal Study on Aging, a population-based study of people aged 45-85 years at baseline. Analyses were limited to individuals either reporting knee OA or no arthritis at baseline (n=21,710). Differences between falling patterns among those with and without knee OA were tested using chi-square tests and multivariable adjusted logistic regression models. An ordinal logistic regression model examined predictors of experiencing one or more injurious falls among individuals with knee OA.

RESULTS: Among individuals reporting knee OA, 10% reported one or more injurious falls; 6% reported 1 fall, 4% reported 2+ falls. Having knee OA significantly contributed to the risk of falling (OR 1.33 [95% CI 1.14-1.56]), and individuals with knee OA were more likely to report having a fall indoors while standing or walking. Among individuals with knee OA, reporting a previous fall (OR 1.75 [95% CI 1.22-2.52]), previous fracture (OR 1.42 [95% CI 1.12-1.80]), and having urinary incontinence (OR 1.38 [95% CI 1.01-1.88]), were significant predictors of falling.

CONCLUSION: Our findings support that knee OA is an independent risk factor for falls. The circumstances in which falls occur differs from those without knee OA. The risk factors and environments that are associated with falling may provide opportunities for clinical intervention and fall prevention strategies. This article is protected by copyright. All rights reserved.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app